Retinosis piigmentaria y edema macular cistoide asociado
Palabras clave:
retinosis pigmentaria, distrofia retinal, edema macular cistoide, inhibidores de la anhidrasa carbónica, dorzolamida, triamcinolona subtenoniana, dexametasona intravítreaResumen
Entre las maculopatías de la retinosis pigmentaria entre el 11 y el 70 % es ocupado por el edema macular cistoide. Se revisaron textos básicos de Oftalmología y se localizaron artículos sobre el tema de los últimos 5 años a través de Google como motor de búsqueda, el directorio LILACS y la consulta de las bases de datos PubMed e Hinari para ampliar el conocimiento sobre el tema y exponer algunos de los tratamientos que se han utilizado recientemente. La literatura publicada acerca de la retinosis pigmentaria, una de las distrofias retinianas frecuente causa de ceguera a nivel mundial, demuestra que aún se investiga esta enfermedad y sus complicaciones haciendo uso de los adelantos más significativos del presente siglo XXI. Se destacan los nuevos hallazgos sobre su fisiopatología y acerca del edema macular cistoide que se asocia en el curso de su evolución natural. Se concluye que la comunidad científica mundial con el desarrollo de múltiples investigaciones continúa aportando nuevos conocimientos sobre la fisiopatología de la retinosis pigmentaria y busca el más adecuado manejo del edema macular cistoide, aún de difícil tratamiento y causa de los cambios atróficos en la fóvea, de la reducción de la agudeza visual y de la calidad de vida del paciente.
Descargas
Citas
Pérez Aguiar LP, García Báez O, Román González C, Menéndez Cepero S. Ozonoterapia y electroestimulación en retinosis pigmentaria. RevIsta Cubana de Oftalmología [Internet] 2010 [citado 08 Jun 2014];23(1). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21762010000100006&script=sci_arttext
Flores P, Loma-Serrano E, Gili P, Carracedo G, Retinitis pigmentosa. Revisión bibliográfica. Gaceta de optometría y óptica oftálmica [Internet] 2013 [citado 08 Jun 2014];(481). Disponible en: www.cnoo.es/download.asp?file=medio/gaceta481/cientifico1.pdf
Herrera Mora M, Barrientos Castaño A, Lima León C, García Báez O. Casanova Rodríguez TA. Retinosis pigmentaria en Cuba. Acta Médica del Centro [Internet] 2013 [citado 08 Jun 2014];6(1). Disponible en: http://www.actamedica.sld.cu/r1_12/pdf/retinosis.pdf
Murakami Y, Miller JW. Rip Kinasa mediated necrosis as an alternative mechanism of photoreceptor death. Oncotarget. 2011;2:497-509.
Gregory-Evans K, Pennesi ME, Weleber RG. Retinitis pigmentosa and allied disorders. En: Ryan SJ. (Eds). Retina I. Philadelphia: Elsevier Inc; 2013; T1.p. 762-822.
Pérez Aguiar LJ, García Báez O. Estrategia cubana para el tratamiento de la retinosis pigmentaria. Rev Cubana Oftalmol [Internet]. 2009 [citado 08 Jun 2014];22(2). Disponible en: http://bvs.sld.cu/revistas/oft/vol22_sup02_09/oft16309.htm
Pérez Machado J, Lie Concepción AE. Apoptosis, mecanismo de acción. Rev Cienc Med Habana [Internet]. 2012 [citado 08 Jun 2014];18(2). Disponible en: http://revcmhabana.sld.cu/index.php/rcmh/article/view/572/html
Rosenbaum DM, Degterev A, David J et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res. 2010;88(7):1569–76.
Ayuso C, Millan JM. Retinitis pigmentosa and allied conditions today: a paradigm of translational research. Genome Medicine [Internet]. 2010 [citado 08 Jun 2014];2(34). Disponible en: http://genomemedicine.com/content/2/5/34
Chang, SV, Olatunji S, Cebulla C, Christoforidis J. Diagnostic challenges in retinitis pigmentosa: Genotypic multiplicity and phenotypic variability. Current Genomics. 2011;12(4):267-275.
Bittner AK, Diener-West M, Dagnelie G. Characteristics and possible visual consequences of photopsias as vision measures are reduced in retinitis pigmentosa, Invest Ophthamol Vis Sci. 2011;52(9):6370-6.
Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Jhohnson LV, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. 2009;27(10):2427-2434.
Benicelli J, Benneti J. Stem cells set their sights on retinitis pigmentosa. eLife [Internet]. 2013 [citado 15 Jul 2014];2. Disponible en: http://elifesciences.org/content/2/e01291
Lobo C. Pathogenesis of pseudophakic cystoid oedema. European Ophthalmic Review [Internet]. 2012 [citado 15 Jul 2014];6(3). Disponible en. http://www.touchophthalmology.com/sites/www.touchophthalmology.com/files/private/articles/1816/pdf/lobo.pdf
Coscas G, Cunha-Vaz J, Soubrane G. Macular Edema: Definition and Basic Concepts. Dev Ophthalmol. 2010;47:1-9.
García-Fernández M, Castro-Navarro J. Bajo-Fuente A. Unilateral recurrent macular hole in a patient with retinitis pigmentosa: a case report. Journal of Medical Case Reports [Internet]. 2013 [citado 25 Jul 2014];7. Disponible en: http://www.jmedicalcasereports.com/content/7/1/69
Oishi A, Otani A, Sahara M et al. Photoreceptor integrity and visual acuity in Cystoid macular oedema asociated with retinitis Pigmentosa. Eye (Lond). 2009;23:1411-6.
Johnson NW. Etiology and treatment of macular edema. Am J Ophtalmol. 2009;147(1):11-21.
Osmann Saatci A, Can Doruk H, Yaman A. Cystoid macular edema in Bietti´s Crystalline Retinopathy. Hindawi Publishing Corporation. Case Reports in Ophthalmological Medicine [Internet]. 2014 [citado 25 Jul 2014];2014(964892). Disponible en: http://www.hindawi.com/journals/criopm/2014/964892/
Sahel JS, Bonnel S, Mrejen S, Pâques M. Retinitis pigmentosa and other dystrophies. Developments in Ophthalmology. 2010:47:160-167.
Fishman GA, Hajali M. Department of Ophthalmology and visual Sciences, University of Illinois, Chicago, IL, USA. The prevalence of cystoid macular edema on optical coherence tomography in retinitis pigmentosa patients without cystic changes in fundus examination. Eye. 2009;23:915-919.
Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Survey of Ophthalmology. 2013;58:560-584.
Hagiwara A, Yamamoto S, Ogata K, Sugawara T, Hiramatsu A, Shibata M, Mitamura Y. Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol. 2011;89:122-125.
Chung H, Hwang JU, Kim JG, Yoon YH. Optical coherence tomography in the diagnosis and monitoring of Cystoid macular edema in patients with Retinitis Pigmentosa. Retina. 2006;26:992-7.
Grover S, Apushkin MA, Fishman GA. Topical dorzolamida for the treatment of Cystoid macular edema associated with Retinitis P. Am J Ophthalmology. 2006;41:850-58.
Yasuhiro I, Toshio H, Noriko Y. The clinical efficacy of a topical dorzolamide in the management of Cystoid macular edema in patients with RP. Graefes Arch Clinic Exp Ophthalmol. 2012;250(6):1-6.
Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA. Effect of Methazolamida on chronic macular edema in patients with Retinitis Pigmentosa. Ophthalmology. 1994;101:687-93.
Osman Saatci A, Can Doruk H, Yaman A. Cystoid Macular Edema in Bietti’s Crystalline Retinopathy. Hindawi Publishing Corporation. Case Reports in Ophthalmological Medicine [Internet]. 2014 [citado 25 Jul 2014];2014. Disponible en: http://www.hindawi.com/journals/criopm/2014/964892/
Broadhead GK, Chang AA. Acetazolamide for cystoid macular oedema in Bietti CrystallineRetinal dystrophy. Korean Journal of Ophthalmology. 2014;28(2):189-191
Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):100-5.
Lijun S, Jianbo M, Yiqi C, Shumao S, Yin H, Lingyun C. Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases. Ophthalmology. 2014;121(3):649-51.
Kovacs K, Wagley S, Quirk MT, Ceron OM, Silva PA, Singh RJ, Gukasyan HJ, Arroyo JG. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior Sub-tenon’s injection. Am Journal of Ophthalmology. 2012;153(5):939-48.
Saatci AO., Selver OB., Seymenoglu G, Yaman A. Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema. Case Rep Ophthalmol [Internet]. 2013 [citado 26 Jun 2014];4(1). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634547/
Srour M, Querques G, Leveziel N, Zerbib J, Tilleul J, Boulanger-Scemama E, Souied EH. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2013;250(6):1-6.
Cho M, D´Amico DJ. Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema. Clinical Ophthalmology. 2012:6:981-89.
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H. Intravitreal Ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. J Ocul Pharmacol Ther. 2009;25(6):545-50.
Arévalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology. 2009;116:1481-7.
De Salvo G, Gemenetzi M, Luff AJ, Lotery J. Cystoid macular oedema successfully treated by cryotherapy in retinitis pigmentosa with Coats'-like retinal exudation. Eye [Internet]. 2011 [citado 15 Ago 2014];25(6). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178146/
Raoof N, Quhill F. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease. Middle East Afr Ophthalmol. 2013;20(3):256-8.
Yoon Jeon K, Soo Geun J, Dong-Hoon L, Joo Yong L, June-Gone K, Young Hee Y. Correlations between Spectral-Domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54(2):1303-1309.
Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literatura review and model. Retina. 2011;31(8):1609-19.
Mitamura Y, Mitamura-Aizawa S, Nagasawa T, Katome T, Eguchi H, Naito T. Diagnostic imaging in patients with retinitis pigmentosa. J Med Invest. 2012;59(1-2):1-11.
Nadler Z, Wollstein G, Ishikawa H, Schuman JS. Clinical application of ocular imaging. Optom Vis Sci [Internet]. 2012 [citado 15 Ago 2014];89(5). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348430/
Guerra García RA. Oftalmología. Criterios y tendencias actuales. La Habana: Ciencias Médicas; 2009. p. 429-8.
Wakabayashi T. Sawa M, Gomi F, Tsujikawa M. Correlation of fundus autofiuorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthamol. 2010:88(5):177-83.
Sugawara T, Sato E, Baba T, Hagiwara A, Tawada A, Yamamoto S. Relationship between vision-related quality of life and microperimetry-determined macular sensitivity in patients with retinitis pigmentosa. Japanese Journal of Ophthalmology. 2011;55(6):643-6.
García-Martin E, Pinilla I, Sancho E, Almarcegui C, Dolz I, Rodríguez-Mena D, Fuertes I, Cuenca N. Optical coherence tomography in retinitis pigmentosa: reproducibility and capacity to detect macular and retinal nerve fiber thickness alterations. Retina. 2012;32(8):1581-91.
Martínez MR, Ophir A. Pseudophakic cystoid macular edema associated with Extrafoveal vitreoretinal traction. The Open Ophthalmology Journal [Internet]. 2011 [citado 15 Ago 2014];5. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104556/
Pinto-Bonilla JC, Olmo-Jimeno A, Llover-Osuna F, Beltrán J, Baviera-Sabater J, Hernández-Galilea E. Multifocal intraocular lenses and cystoid macular edema: a multicenter study. J Emetropia [Internet]. 2013 [citado 15 Ago 2014];4. Disponible en: http://www.clinicabaviera.com/actividades_medicas/multifocal-intraocular-lenses-and-cystoid-1375693671.pdf
Domanico D, Carnevale C, Fragiotta S, Verboshi F, Altimari S, Vingolo E.M. Cystoid macular Edema induced by low doses of nicotinic acid. Case Reports in Ophthalmological Medicine [Internet]. 2013 [citado 15 Ago 2014];2013. Disponible en: http://www.hindawi.com/journals/criopm/2013/713061/
